Hong Kong start-up Prenetics to list in the U.S. through $1.7 billion SPAC deal Hong Kong biotech company Prenetics is going public through a merger with Artisan Acquisition — a SPAC backed by Adrian Cheng, CEO of New World Development.
from Top News and Analysis (pro)
via By Anand Gupta
from Top News and Analysis (pro)
via By Anand Gupta
Tags
Finance and Accounting Blogs
Financial Blogs
Hong Kong start-up Prenetics to list in the U.S. through $1.7 billion SPAC deal
Mr. Anand Gupta
the anand gupta show
Top News and Analysis (pro)